<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 52-year-old woman, previously treated with chemo- and radiotherapy for <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, developed an <z:hpo ids='HP_0011009'>acute</z:hpo> non-<z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo> and, contemporarily, an IgG-kappa <z:e sem="disease" ids="C0030489" disease_type="Disease or Syndrome" abbrv="">paraproteinemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Cytogenetic analysis showed a major clone, representing 90% of observed metaphases, with <z:mp ids='MP_0004026'>monosomy</z:mp> of chromosomes 5 and 14 </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, leukemic cells exhibited a high expression of the P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, a transmembrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> involved in the multidrug-resistance mechanism </plain></SENT>
<SENT sid="3" pm="."><plain>Possible explanations for this cluster of findings are provided </plain></SENT>
</text></document>